John A. Roberts - 24 May 2021 Form 4/A - Amendment Insider Report for Vyant Bio, Inc.

Role
Chief Executive Officer
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
24 May 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
25 Aug 2021, 16:59:32 UTC
Date Of Original Report
27 May 2021
Next filing
25 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VYNT Common Stock, $0.0001 par value 24,401 24 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 27, 2021, the reporting person filed a Form 4, which inadvertently reported the shares owned on a pre-split basis. This amended Form 4 is being filed to reflect the shares owned following the 1-for-30 reverse stock split effected October 24, 2019.